Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,681 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
115年05月僑外投資持股
Regulatory Filings Classification · 66% confidence The document is a statutory disclosure from Taiwan’s public information platform detailing aggregated holdings of overseas Chinese, foreign, and mainland investors (a regulatory table), including pre- and post-shareholder meeting balances. It is not an earnings release, financial report, proxy statement, or management presentation. Instead, it is a routine regulatory filing to the exchange that does not fall under more specific categories like major shareholding threshold notices (MRQ) or share issuance (SHA). Therefore it fits the generic Regulatory Filings category (RNS).
2026-05-22 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed consolidated statement of changes in equity (“合併權益變動表”) showing actual financial figures for the first quarter of the fiscal year and comparative prior period data. It is part of interim financial statements rather than an announcement or summary. This aligns with the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Chinese
115年第1季現金流量表
Interim / Quarterly Report Classification · 90% confidence The document is titled “合併現金流量表” and provides detailed line‐by‐line cash flow data for the first quarter of fiscal year 115 (Minguo calendar), with comparative figures for the prior year’s same period. It is substantive financial statement content (cash flows from operating, investing, and financing activities) for a quarter period, not merely an announcement or certification. This fits the definition of an Interim / Quarterly Report. Q1 2026
2026-05-15 Chinese
115年第1季綜合損益表
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated statement of comprehensive income (‘合併綜合損益表’) for the first quarter (民國115年第1季) with actual line‐by‐line financial data (revenues, costs, expenses, net profit, EPS, etc.). It is not merely an announcement or link to a report, nor an officer certification, but a substantive quarterly financial statement. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 92% confidence The document is a standalone consolidated balance sheet (‘合併資產負債表’) showing actual figures for the first quarter of fiscal year 115 (民國115年第1季) alongside comparative periods. It contains substantive financial data for a period shorter than a full year, indicating it is part of an interim/quarterly financial report rather than merely an announcement or supplement. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Chinese
更正本公司115年第1季會計師查核報告意見類型
Report Publication Announcement Classification · 82% confidence The document is a brief announcement on the company’s public disclosure platform stating that its Q1 audit report opinion type has been corrected and re-uploaded. It does not contain the full audit report or substantive financial data itself but simply advises that the corrected report is now published. Under the “menu vs meal” rule, such short notices of a report upload or correction are classified as a Report Publication Announcement (RPA).
2026-05-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.